Induction of ischemic tolerance protects the retina from diabetic retinopathy

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 2264-2274

  Fernandez, Diego C ^a,b   Sande, Pablo H ^a   Chianelli, Mónica S ^a   Marcos, Hernán J Aldana ^b,c   Rosenstein, Ruth E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD DE MORÓN   (Argentina)

^c UNIVERSIDAD DE BELGRANO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; EVANS BLUE; GLIAL FIBRILLARY ACIDIC PROTEIN; STREPTOZOCIN; VASCULOTROPIN;

A WAVE; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; B WAVE; BLOOD RETINA BARRIER; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRON MICROSCOPY; EYE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJECTION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; ISCHEMIC POSTCONDITIONING; MALE; MICROSCOPY; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; RAT; RETINA; RETINA EDEMA; RETINA ISCHEMIA; SHAM PROCEDURE; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

EID: 79959282281     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.040     Document Type: Article

References (52)

1. Kern TS, Barber AJ: Retinal ganglion cells in diabetes. J Physiol 2008, 586:4401-4408
2. Kowluru RA, Chan PS: Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007, 2007:43603-43614
3. Zhang X, Bao S, Hambly BD, Gillies MC: Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy. Int J Biochem Cell Biol 2009, 41:2368-2371
4. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA; JDRF Diabetic Retinopathy Center Group: Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55:2401-2411
5. Yu PK, Yu DY, Alder VA, Su EN, Cringle SJ: Intracellular structures of retinal vascular endothelium in normal and early diabetic rats. Aust N Z J Ophthalmol 1998, 26:S53-55
6. Wei M, Ong L, Smith MT, Ross FB, Schmid K, Hoey AJ, Burstow D, Brown L: The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart Lung Circ 2003, 12:44-50 (Pubitemid 36940012)
7. Kern TS: In vivo models of diabetic retinopathy. Diabetic retinopathy. Edited by EJ Duh. Totowa, NY, Humana Press, 2009, pp 137-156
8. Harhaj NS, Antonetti DA: Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 2004, 36:1206-1237 (Pubitemid 38519069)
9. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 1998, 21:143-156 (Pubitemid 28030402)
10. Frank RN: On the pathogenesis of diabetic retinopathy: a 1990 update. Ophthalmology 1991, 98:586-593
11. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein IM, Maxwell KM, Gidday JM: Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci 1998, 39:777-785 (Pubitemid 28207473)
12. Roth S: Endogenous neuroprotection in the retina. Brain Res Bull 2004, 62:461-466
13. Gidday JM: Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006, 7:437-448
14. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehülsing GJ, Brunecker P, Müller B, Banasik A, Amberger N, Wernecke KD, Siebler M, Röther J, Villringer A, Weih M; MRI in Acute Stroke Study Group of the German Competence Network Stroke: Transient ischemic attacks before ischemic stroke: preconditioning the human brain? a multicenter magnetic resonance imaging study. Stroke 2004, 35:616-621 (Pubitemid 38280829)
15. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, Hong SK: Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J 1996, 132:78-83
16. Zhao H, Sapolsky RM, Steinberg GK: Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 2006, 26:1114-1121 (Pubitemid 44268173)
17. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, Gala R, Simon RP: In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 2008, 28:232-241
18. Fernandez DC, Bordone MP, Chianelli MS, Rosenstein RE: Retinal neuroprotection against ischemia-reperfusion damage induced by postconditioning. Invest Ophthalmol Vis Sci 2009, 50:3922-3930
19. Ma N, Hunt NH, Madigan MC, Chan-Ling T: Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol 1996, 149:1745-1762 (Pubitemid 26363980)
20. DePace DM: Distribution of intravascularly injected lanthanum ions in ganglia of the autonomic nervous system of the rat. J Auton Nerv Syst 1984, 11:339-347
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin Phenol reagent. J Biol Chem 1951, 193:265-275
22. Shinoda K, Rejdak R, Schuettauf F, Blatsios G, Völker M, Tanimoto N, Olcay T, Gekeler F, Lehaci C, Naskar R, Zagorski Z, Zrenner E: Early electroretinographic features of streptozotocin-induced diabetic retinopathy. Clin Experiment Ophthalmol 2007, 35:847-854
23. Hancock HA, Kraft TW: Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004, 45:1002-1008 (Pubitemid 38868404)
24. Heynen H, Wachtmeister L, van Norren D: Origin of the oscillatory potentials in the primate retina. Vision Res 1985, 25:1365-1373 (Pubitemid 16235074)
25. Wachtmeister L: Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 1998, 17:485-521
26. Rangaswamy NV, Zhou W, Harwerth RS, Frishman LJ: Effect of experimental glaucoma in primates on oscillatory potentials of the slowsequence mfERG. Invest Ophthalmol Vis Sci 2006, 47:753-767 (Pubitemid 46768407)
27. Rosenbaum DM, Rosenbaum PS, Singh M, Gupta G, Gupta H, Li B, Roth S: Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J Neuroophthalmol 2001, 21:62-68 (Pubitemid 32217103)
28. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest 1998, 102: 783-791 (Pubitemid 28399611)
29. Meyer-Rüsenberg B, Pavlidis M, Stupp T, Thanos S: Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy. Graefes Arch Clin Exp Ophthalmol 2007, 245:1009-1018
30. Zhang SX, Ma JX, Sima J, Chen Y, Hu MS, Ottlecz A, Lambrou GN: Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol 2005, 166:313-321 (Pubitemid 40051683)
31. Schnitzer J: Astrocytes in the guinea pig, horse, and monkey retina: their occurrence coincides with the presence of blood vessels. Glia 1988,1: 74-89
32. Zhang Y, Stone J: Role of astrocytes in the control of developing retinal vessels. Invest Ophthalmol Vis Sci 1997, 38:1653-1666 (Pubitemid 27382331)
33. Gardner TW: Histamine. ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy Trans Am Ophthalmol Soc 1995, 93:583-621
34. Chan-Ling T, Stone J: Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci 1992, 33:2148-2159
35. Gardner TW, Lieth E, Khin SA, Barber AJ, Bonsall DJ, Lesher T, Rice K, Brennan WA Jr: Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 1997, 38:2423-2427 (Pubitemid 27446958)
36. Rungger-Brändle E, Dosso AA, Leuenberger PM: Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000, 41:1971-1980 (Pubitemid 30354375)
37. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M: A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003, 52:506-511 (Pubitemid 36173210)
38. Barber AJ, Antonetti DA, Gardner TW; The Penn State Retina Research Group: Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 2000, 41:3561-3568
39. Vinores SA, Derevjanik NL, Mahlow J, Berkowitz BA, Wilson CA: Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging. Pathol Res Pract 1998, 194:497-505 (Pubitemid 28393714)
40. Caldwell RB, Slapnick SM: Freeze-fracture and lanthanum studies of the retinal microvasculature in diabetic rats. Invest Ophthalmol Vis Sci 1992, 33:1610-1619
41. Kaur C, Foulds WS, Ling EA: Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 2008, 27:622-647
42. Lutty GA, McLeod DS, Merges C, Diggs A, Plouét J: Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996, 114:971-977 (Pubitemid 26271463)
43. Aiello LP, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl 2000, 77:S113-S119
44. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996, 103:1820-1828 (Pubitemid 26403735)
45. Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA: Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol 2002, 133:373-385 (Pubitemid 34171588)
46. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME: Pan-American Collaborative Retina Study Group: primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007, 114:743-750 (Pubitemid 46483714)
47. Ng EW, Adamis AP: Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases. Ann N Y Acad Sci 2006, 1082:151-171 (Pubitemid 44955460)
48. Li B, Yang C, Rosenbaum DM, Roth S: Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp Eye Res 2000, 70:755-765
49. Sakamoto K, Kuwagata M, Nakahara T, Ishii K: Late preconditioning in rat retina: involvement of adenosine and ATP-sensitive K(+) channel. Eur J Pharmacol 2001, 418:89-93 (Pubitemid 32378814)
50. Sakamoto K, Yonoki Y, Kubota Y, Kuwagata M, Saito M, Nakahara T, Ishii K: Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina. Exp Eye Res 2006, 82:512-518 (Pubitemid 43140720)
51. Starita C, Patel M, Katz B, Adamis AP: Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy. Dev Ophthalmol 2007, 39:122-148
52. Whitlock NA, Agarwal N, Ma JX, Crosson CE: Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci 2005, 46:1092-1098 (Pubitemid 41321050)